Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | News and Research on Pharma , Bio Tech, Clinical Trials and Clinical Research - PharmaNewsIntelligence |
Description | The Latest News and Research on Pharma , Bio Tech, Clinical Trials and Clinical Research |
Keywords | N/A |
WebSite | www.pharmanewsintel.com |
Host IP | 104.26.11.149 |
Location | United States |
Site | Rank |
rxdatascience.com | #1,400,775 |
scienceboard.net | #509,165 |
datakitchen.io | #835,484 |
pidecomida.net |
philhuntparts.com.au |
pineapplie.wordpress.com |
pilatesequipment.fitness |
pipminds.com |
plantasde.es |
platamex.com |
plancaribe.com |
playmotiv.com |
planeta.website |
klotzfiber.com |
kowasposr.pw |
US$12,417
Last updated: Aug 22, 2020
Pharmanewsintel.com has global traffic rank of 1,377,454. Pharmanewsintel.com has an estimated worth of US$ 12,417, based on its estimated Ads revenue. Pharmanewsintel.com receives approximately 2,268 unique visitors each day. Its web server is located in United States, with IP address 104.26.11.149. According to SiteAdvisor, pharmanewsintel.com is safe to visit. |
Purchase/Sale Value | US$12,417 |
Daily Ads Revenue | US$6 |
Monthly Ads Revenue | US$204 |
Yearly Ads Revenue | US$2,483 |
Daily Unique Visitors | 2,268 |
Note: All traffic and earnings values are estimates. |
Global Rank | 1,377,454 |
Delta (90 Days) | 0 |
Most Popular In Country | N/A |
Country Rank | N/A |
Host | Type | TTL | Data |
pharmanewsintel.com | A | 299 | IP: 104.26.10.149 |
pharmanewsintel.com | A | 299 | IP: 104.26.11.149 |
pharmanewsintel.com | A | 299 | IP: 172.67.70.13 |
pharmanewsintel.com | AAAA | 299 | IPv6: 2606:4700:20:0:0:0:681a:a95 |
pharmanewsintel.com | AAAA | 299 | IPv6: 2606:4700:20:0:0:0:ac43:460d |
pharmanewsintel.com | AAAA | 299 | IPv6: 2606:4700:20:0:0:0:681a:b95 |
pharmanewsintel.com | NS | 21599 | Target: sandy.ns.cloudflare.com. |
pharmanewsintel.com | NS | 21599 | Target: bart.ns.cloudflare.com. |
pharmanewsintel.com | TXT | 299 | TXT: ca3-5a560392c88d42bdbafc7a06a543b9f9 |
pharmanewsintel.com | SOA | 3599 | MNAME: bart.ns.cloudflare.com. RNAME: dns.cloudflare.com. Serial: 2034518165 Refresh: 10000 Retry: 2400 Expire: 604800 Minimum TTL: 3600 |
HTTP/1.1 301 Moved Permanently Date: Sat, 22 Aug 2020 22:18:21 GMT Content-Type: text/html; charset=iso-8859-1 Transfer-Encoding: chunked Connection: keep-alive Set-Cookie: __cfduid=d228d1d12d80fa1846fc5241fc113ff3c1598134701; expires=Mon, 21-Sep-20 22:18:21 GMT; path=/; domain=.pharmanewsintel.com; HttpOnly; SameSite=Lax Location: https://pharmanewsintel.com/ CF-Cache-Status: DYNAMIC cf-request-id: 04b9d9643400000ce17ca60200000001 Server: cloudflare CF-RAY: 5c6ff819e8790ce1-EWR HTTP/2 200 date: Sat, 22 Aug 2020 22:18:22 GMT content-type: text/html; charset=UTF-8 set-cookie: __cfduid=d994f5b651abe3929d038eb7ff15e108d1598134701; expires=Mon, 21-Sep-20 22:18:21 GMT; path=/; domain=.pharmanewsintel.com; HttpOnly; SameSite=Lax set-cookie: exp_last_visit=1282774701; expires=Sun, 22-Aug-2021 22:18:21 GMT; Max-Age=31536000; path=/; domain=.pharmanewsintel.com; secure; HttpOnly set-cookie: exp_last_activity=1598134701; expires=Sun, 22-Aug-2021 22:18:21 GMT; Max-Age=31536000; path=/; domain=.pharmanewsintel.com; secure; HttpOnly set-cookie: exp_csrf_token=deleted; expires=Thu, 01-Jan-1970 00:00:01 GMT; Max-Age=0; path=/; domain=.pharmanewsintel.com; secure; HttpOnly set-cookie: exp_csrf_token=8747b0a437c179792d9e5445e74167ff12884d16; expires=Sun, 23-Aug-2020 00:18:21 GMT; Max-Age=7200; path=/; domain=.pharmanewsintel.com; secure; HttpOnly x-frame-options: SAMEORIGIN expires: Mon, 26 Jul 1997 05:00:00 GMT last-modified: Sat, 22 Aug 2020 22:18:22 GMT pragma: no-cache vary: Accept-Encoding x-hostname: ece006-fs1.nexcess.net cf-cache-status: DYNAMIC cf-request-id: 04b9d9648a0000156fd01fc200000001 expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct" server: cloudflare cf-ray: 5c6ff81a7ac6156f-EWR |
Not Available |